C12Y 207/07049
Rna-directed dna polymerase , i.e. telomerase or reverse-transcriptase
Official title: RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
C12Y207/07049 (Rna-directed dna polymerase , i.e. telomerase or reverse-transcriptase) appears on 375 US grants and 733 published applications in this corpus.
Search patents in C12Y- Granted patents
- 375
- Published applications
- 733
- Assignees
- 295
- Inventors
- 1,221
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 9 | 0 |
| 1999 | 11 | 0 |
| 2000 | 7 | 0 |
| 2001 | 9 | 1 |
| 2002 | 5 | 7 |
| 2003 | 14 | 31 |
| 2004 | 6 | 17 |
| 2005 | 3 | 53 |
| 2006 | 6 | 7 |
| 2007 | 6 | 11 |
| 2008 | 2 | 11 |
| 2009 | 10 | 17 |
| 2010 | 8 | 5 |
| 2011 | 11 | 15 |
| 2012 | 3 | 10 |
| 2013 | 5 | 13 |
| 2014 | 8 | 11 |
| 2015 | 11 | 28 |
| 2016 | 12 | 31 |
| 2017 | 25 | 30 |
| 2018 | 20 | 29 |
| 2019 | 16 | 25 |
| 2020 | 13 | 24 |
| 2021 | 23 | 37 |
| 2022 | 21 | 37 |
| 2023 | 23 | 48 |
| 2024 | 28 | 74 |
| 2025 | 22 | 83 |
| 2026 | 22 | 78 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Inactive telomerase, adenovirus associated virus and artificial mRNA having same and use thereof22 Sep 2026US 12,742,161 B2Nanjing Juvensis Therapuetics Co., Ltd.
- Compositions and methods for delivery of RNA1 Sep 2026US 12,721,818 B2Rejuvenation Technologies, Inc.
- Recombinant adeno-associated viral vectors for delivering a therapeutic gene to lungs30 Jun 2026US 12,668,817 B1Telomere Therapeutics S.L.
- Protein constructs of moloney murine leukemia virus reverse transcriptase (MMLV-RT)16 Jun 2026US 12,655,401 B2Integreon Global, Inc.
- Reverse transcriptase with improved properties8 Oct 2026US 2026/0308541 A1
- Transcriptional recording by crispr spacer acquisition from rna1 Oct 2026US 2026/0297595 A1ETH Zurich
- Compositions and methods for upregulation of reverse transcription and reduction of sequence bias in rna sequencing1 Oct 2026US 2026/0297666 A1
- Composition comprising gv1001 for preventing or treating macular degeneration24 Sep 2026US 2026/0284152 A1GemVax & KAEL Co., Ltd.
- Strand-displacing dna polymerases17 Sep 2026US 2026/0275306 A1Varigen Biosciences Corporation
Most cited
By later US patents
- Multiponent adult stem cells and methods for isolation161US 7,015,037 B1M.C.L. Co., Ltd. · 2006
- Cloned genes encoding reverse transcriptase lacking RNase H activity143US 5,244,797 ALife Technologies Corporation · 1993
- Therapy and diagnosis of conditions related to telomere length and/or telomerase activity143US 5,489,508 AUniversity of Texas System Board of Regents · 1996
- Mammalian telomerase139US 5,583,016 AGeron Corporation · 1996
- Cloned genes encoding reverse transcriptase lacking RNase H activity101US 5,405,776 ALife Technologies Corporation · 1995